Andrea Ferrigno
Overview
Explore the profile of Andrea Ferrigno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
759
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Vairetti M, Colucci G, Ferrigno A
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35887242
Nonalcoholic fatty liver disease (NAFLD) is among the most common liver diseases worldwide, affecting up to 20-30% of the human population [...].
12.
Palladini G, Di Pasqua L, Cagna M, Croce A, Perlini S, Mannucci B, et al.
Int J Mol Sci
. 2022 Jun;
23(12).
PMID: 35743260
We evaluate the effects of the methionine-choline-deficient (MCD) diet on serum and hepatic zinc (Zn) and iron (Fe) and their relationships with matrix metalloproteinases (MMPs) and their modulators (TIMPs and...
13.
Palladini G, Cagna M, Di Pasqua L, Adorini L, Croce A, Perlini S, et al.
Pharmaceuticals (Basel)
. 2022 May;
15(5).
PMID: 35631351
We have previously demonstrated that the farnesoid X receptor (FXR) agonist obeticholic acid (OCA) protects the liver via downregulation of hepatic matrix metalloproteinases (MMPs) after ischemia/reperfusion (I/R), which can lead...
14.
Di Pasqua L, Berardo C, Raffo L, Ferrigno A, Guffanti E, Vairetti M
Int J Environ Res Public Health
. 2022 Feb;
19(4).
PMID: 35206356
In Italy, peat extracted from the peat bogs of Lake Massaciuccoli is the only peat used for therapeutic purposes. Massaciuccoli peat (M-peat) soaked in the salty bromine-iodine water of Undulna...
15.
Di Pasqua L, Cagna M, Berardo C, Vairetti M, Ferrigno A
Biomedicines
. 2022 Jan;
10(1).
PMID: 35052872
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are some of the biggest public health challenges due to their spread and increasing incidence around the world. NAFLD is characterized...
16.
Di Pasqua L, Berardo C, Cagna M, Mannucci B, Milanesi G, Croce A, et al.
Lipids Health Dis
. 2021 Jul;
20(1):78.
PMID: 34320998
Background: Waiting lists that continue to grow and the lack of organs available for transplantation necessitate the use of marginal livers, such as fatty livers. Since steatotic livers are more...
17.
Vairetti M, Di Pasqua L, Cagna M, Richelmi P, Ferrigno A, Berardo C
Antioxidants (Basel)
. 2021 Mar;
10(3).
PMID: 33670839
Glutathione (GSH), a tripeptide particularly concentrated in the liver, is the most important thiol reducing agent involved in the modulation of redox processes. It has also been demonstrated that GSH...
18.
Di Pasqua L, Berardo C, Cagna M, Verta R, Collotta D, Nicoletti F, et al.
Int J Mol Sci
. 2021 Mar;
22(5).
PMID: 33668105
We previously demonstrated that the blockade of mGluR5 by 2-methyl-6(phenylethynyl)pyridine (MPEP) reduces both cold and warm ischemia/reperfusion injury. Here we evaluated whether MPEP reduces the hepatic preservation injury in rat...
19.
Croce A, Ferrigno A, Bottiroli G, Di Pasqua L, Berardo C, Vairetti M
J Photochem Photobiol B
. 2021 Jan;
215:112121.
PMID: 33422899
The bichromophore nature of bilirubin explains the presence of at least two partially overlaying bands in both absorption and fluorescence emission spectra, and accounts for interchromophore exciton transfer events responsible...
20.
Berardo C, Di Pasqua L, Cagna M, Richelmi P, Vairetti M, Ferrigno A
Int J Mol Sci
. 2020 Dec;
21(24).
PMID: 33348908
Nonalcoholic fatty liver disease (NAFLD) is a continuum of liver abnormalities often starting as simple steatosis and to potentially progress into nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis and hepatocellular carcinoma. Because...